Caregiver Solutions for Dementia Patients

Dementia Clinical Trial

Official title:

Identifying Specifications for Caregiver-assisted Solutions to Assess Dementia Patient Needs at Home

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05888610
• Other study ID #: 00109123
• Status: Completed
• Phase: N/A
• Start date: June 12, 2023
• Est. completion date: July 12, 2023

Study information

• Verified date: November 2023
• Source: Prepped Health LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to test a mobile application amongst caregiver's supporting patients diagnosed with Alzheimer's Disease and Related Dementias (ADRD). The main question it aims to answer is: Will caregivers supporting patients diagnosed with ADRD utilize a mobile application to routinely report symptoms of the patients they care for?

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: July 12, 2023
• Est. primary completion date: July 12, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Caregiver of a Duke patient with Alzheimer's disease or Alzheimer's disease-related dementias (ADRD), participating in the Duke Dementia Family Support Program

• The ability to speak and understand English

• Age > 18 years

Exclusion Criteria:

• Those unable to speak and understand English

• Age = 18 years

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease
• Caregivers
• Dementia
• Remote Monitoring

Intervention

Behavioral:
• Digital Outpost
A mobile application that allows caregivers of patients diagnosed with Alzheimer's Disease and Related Dementias to report patient symptom remotely to their clinical team.

Locations

Country	Name	City	State
United States	Duke University	Durham	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Prepped Health LLC	Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Days that Participants Use Digital Outpost	Completion of at least 75% of Digital Outpost across 4 days within a 2-week period	Time Frame up to week 2
Primary	Number of Clinical Assessments Completed	Completion of at least 75% of Clinical Assessments	Time Frame up to week 2
Secondary	Usability as Measured by the System Usability Scale at 2 weeks	The System Usability Scale will be used for rating technology usability. The measure has 10 items. Each item is measured on a 10-point scale ranging from 0-10. The total score ranges from 0-100, where higher scores indicate greater usability.	Time Frame 2 weeks